STAT+: What to expect at the ASH meeting, and some thoughts on the FDA’s Richard Pazdur
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to ...
BANGOR — Steven Cronk, 41, sleeps among a row of tattered, sun-bleached tents that cling to a small strip of ...
WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
President Trump described his administration’s agreement with Pfizer on several drug pricing plans as a historic measure to lower costs ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Dear Readers, The news seems unrelenting these days, and when it comes to health and medicine, it’s all the more ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.